Pulmonary hypertension, Internal medicine, BMPR2, Endocrinology and Pathology are his primary areas of study. His Pulmonary hypertension research is multidisciplinary, incorporating elements of Respiratory disease, Lung, Cancer research, Hypoxia and Pulmonary artery. His research investigates the connection between Internal medicine and topics such as Gastroenterology that intersect with problems in Surgery and COPD.
His biological study spans a wide range of topics, including Mutation, Endoglin and Cell biology. Nicholas W. Morrell interconnects Bone morphogenetic protein receptor and Cell growth in the investigation of issues within Endocrinology. His studies deal with areas such as Receptor, Signal transduction and SMAD as well as Bone morphogenetic protein.
His primary areas of study are Internal medicine, Pulmonary hypertension, Endocrinology, BMPR2 and Bone morphogenetic protein. His research integrates issues of Gastroenterology and Cardiology in his study of Internal medicine. Nicholas W. Morrell has included themes like Respiratory disease, Lung, Hypoxia, Immunology and Pathology in his Pulmonary hypertension study.
His Endocrinology study frequently intersects with other fields, such as Right ventricular hypertrophy. The BMPR2 study combines topics in areas such as Mutation, Cancer research and Bone morphogenetic protein receptor. His Bone morphogenetic protein study integrates concerns from other disciplines, such as Receptor, Signal transduction, Cell biology, Transforming growth factor and SMAD.
Nicholas W. Morrell spends much of his time researching Internal medicine, BMPR2, Pulmonary hypertension, Disease and Cancer research. His Internal medicine research is multidisciplinary, relying on both Gastroenterology, Endocrinology, Oncology and Cardiology. His BMPR2 research includes elements of Mutation, Lung and Bone morphogenetic protein receptor.
Nicholas W. Morrell focuses mostly in the field of Pulmonary hypertension, narrowing it down to topics relating to Pathogenesis and, in certain cases, Immune system. His Cancer research research incorporates elements of Apoptosis, Endothelium and Signal transduction. His Bone morphogenetic protein study combines topics from a wide range of disciplines, such as Receptor, Cell type and Cell biology.
Nicholas W. Morrell mainly focuses on Internal medicine, Pulmonary hypertension, BMPR2, Disease and Mutation. His studies in Internal medicine integrate themes in fields like RNA, Endocrinology and Oncology. His Pulmonary hypertension research integrates issues from Pregnancy, Clinical trial, Vascular resistance, Vascular structure and Biomarker.
The study incorporates disciplines such as Cancer research, Bone morphogenetic protein receptor, Translationally-controlled tumor protein, Molecular genetics and Gene silencing in addition to BMPR2. His research in Disease intersects with topics in Quantitative trait locus and Mendelian inheritance. His Mutation study combines topics in areas such as Computational biology and Genomics.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Cellular and molecular pathobiology of pulmonary arterial hypertension.
Marc Humbert;Nicholas W Morrell;Stephen L Archer;Kurt R Stenmark.
Journal of the American College of Cardiology (2004)
Cellular and molecular basis of pulmonary arterial hypertension.
Nicholas W. Morrell;Serge Adnot;Stephen L. Archer;Jocelyn Dupuis.
Journal of the American College of Cardiology (2009)
Clinical and molecular genetic features of pulmonary hypertension in patients with hereditary hemorrhagic telangiectasia
Richard Trembath;J R Thomson;Rajiv Machado;N Morgan.
The New England Journal of Medicine (2001)
Inflammation, growth factors, and pulmonary vascular remodeling.
Paul M. Hassoun;Luc Mouthon;Joan A. Barberà;Saadia Eddahibi.
Journal of the American College of Cardiology (2009)
Primary pulmonary hypertension is associated with reduced pulmonary vascular expression of type II bone morphogenetic protein receptor.
Carl Atkinson;Susan Stewart;Paul D. Upton;Rajiv D. Machado.
Circulation (2002)
Elevated Levels of Inflammatory Cytokines Predict Survival in Idiopathic and Familial Pulmonary Arterial Hypertension
Elaine Soon;Alan M. Holmes;Carmen M. Treacy;Natalie J. Doughty.
Circulation (2010)
Altered Growth Responses of Pulmonary Artery Smooth Muscle Cells From Patients With Primary Pulmonary Hypertension to Transforming Growth Factor-β1 and Bone Morphogenetic Proteins
Nicholas W. Morrell;Xudong Yang;Paul D. Upton;Karen B. Jourdan.
Circulation (2001)
Sildenafil Inhibits Hypoxia-Induced Pulmonary Hypertension
L. Zhao;N.A. Mason;N.W. Morrell;B. Kojonazarov.
Circulation (2001)
Imatinib Mesylate as Add-On Therapy for Pulmonary Arterial Hypertension: Results of the Randomized IMPRES Study
Marius M. Hoeper;Robyn J. Barst;Robert C. Bourge;Jeremy Feldman.
Circulation (2013)
Mutations of the TGF-beta type II receptor BMPR2 in pulmonary arterial hypertension.
Rajiv D. Machado;Micheala A. Aldred;Victoria James;Rachel E. Harrison.
Human Mutation (2006)
Pulmonary Circulation
(Impact Factor: 2.886)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
King's College London
University of Paris-Saclay
University of Colorado Denver
Newcastle University
Université Paris Cité
University of Paris-Saclay
University of Giessen
University of California, San Diego
University of Giessen
University of Giessen
University of Melbourne
MIT
University of Electronic Science and Technology of China
Super Talent Electronics, Inc
Newcastle University
National Center for Nanoscience and Technology, China
Sichuan University
South Australian Museum
Paracelsus Medical University
University of Western Australia
University of Arizona
Skidaway Institute of Oceanography
University of Milan
University of Otago
Roswell Park Cancer Institute
Wayne State University